A double-blinded, randomised, two-period crossover Euglycemic Clamp Trial investigating the pharmacokinetics, glucodynamics and safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog) in subjects with type 1 diabetes

Trial Profile

A double-blinded, randomised, two-period crossover Euglycemic Clamp Trial investigating the pharmacokinetics, glucodynamics and safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog) in subjects with type 1 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs Insulin lispro (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Adocia
  • Most Recent Events

    • 16 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
    • 02 Sep 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
    • 15 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top